When did Protagonist Therapeutics report Q4 2024 earnings?

Protagonist Therapeutics (PTGX) reported Q4 2024 earnings on February 21, 2025 before market open.

What were Protagonist Therapeutics's Q4 2024 revenue and EPS?

Protagonist Therapeutics reported revenue of $170.6M and eps of $1.98 for Q4 2024.

Did Protagonist Therapeutics beat estimates in Q4 2024?

Revenue beat the consensus estimate of $81.0M by $89.6M. EPS beat the consensus estimate of $0.06 by $1.92.

Where can I find Protagonist Therapeutics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001558370-25-001317) directly on SEC EDGAR. The filing index links above go to sec.gov.

Protagonist Therapeutics PTGX Q4 2024 Annual earnings

Reported February 21, 2025 · Before market open

Revenue$170.6MBeat by $89.6M

EPS$1.98Beat by $1.92

Revenue estimate$81.0M

EPS estimate$0.06

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$199.8M

EPS estimate$2.11

Financials

Q4 2024

Income statement

See full

Revenue$170.6M+184%

Operating income$126.8M—

Net income$131.7M—

EPS (diluted)$2.01—

Balance sheet

See full

Cash & equivalents$97.2M-47.9%

Total debt$10.9M+852%

Total equity$675.3M+101%

Total assets$744.7M+108%

Cash flow

See full

CapEx$310.0K+1,532%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$2.3B+66.1%

Enterprise value$2.21B+84.6%

P/E8.4×—

P/S5.3×-17.8×

Profitability

See full

Operating margin58.2%—

Net margin63.3%—

Returns & leverage

See full

Return on equity54.4%—

Debt / equity0×0.0×

Current ratio12.5×-4.2×

Segments

By segment

See full

Single Reportable$170.6M+1,038%

Versus estimates

Revenue

Q1 2026$56.4MBeat by $44.7M Q4 2025$7.4MMiss by $1.3M Q3 2025$4.7MMiss by $10.2M Q2 2025$5.5MMiss by $2.9M Q1 2025$28.3MBeat by $21.8M

Q4 2024$170.6MBeat by $89.6M

Diluted EPS

Q1 2026$0.05Beat by $0.70 Q4 2025-$0.69Miss by $0.16 Q3 2025-$0.62Miss by $0.03 Q2 2025-$0.55Miss by $0.02 Q1 2025-$0.19Beat by $0.31

Q4 2024$1.98Beat by $1.92

Ask the moment Protagonist Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Protagonist Therapeutics report Q4 2024 earnings?: Protagonist Therapeutics (PTGX) reported Q4 2024 earnings on February 21, 2025 before market open.
What were Protagonist Therapeutics's Q4 2024 revenue and EPS?: Protagonist Therapeutics reported revenue of $170.6M and eps of $1.98 for Q4 2024.
Did Protagonist Therapeutics beat estimates in Q4 2024?: Revenue beat the consensus estimate of $81.0M by $89.6M. EPS beat the consensus estimate of $0.06 by $1.92.
Where can I find Protagonist Therapeutics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001558370-25-001317) directly on SEC EDGAR. The filing index links above go to sec.gov.